Why is Beryl Drugs falling/rising?

As of 06-Oct, Beryl Drugs Ltd is experiencing a price increase, currently at 23.99, with a change of 0.54, representing a 2.3% rise. The stock has shown strong performance recently, gaining 7.87% over the last two days and outperforming its sector by 2.19%. In terms of longer-term performance, the stock has increased by 7.82% over the past week, although it has seen a slight decline of 0.08% over the past month. Notably, the stock's delivery volume has surged by 287.03% against the five-day average, indicating rising investor participation. However, there is no information available regarding positive or negative factors that could influence the stock's movement.
In the broader market context, Beryl Drugs' recent short-term return of 7.82% over the past week significantly outpaces the Sensex, which has only increased by 1.77% in the same period. This suggests that the stock is gaining traction relative to the market, despite its year-to-date decline of 33.64% compared to the Sensex's rise of 4.67%. The stock's current price is above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average, indicating a potential upward trend in the short term amidst a challenging longer-term performance.